“Efficacy and Safety of Tralokinumab in US Adults With Moderate-to-Severe Atopic Dermatitis: A Post-Hoc Analysis of ECZTRA3”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, pp. 686-95, https://doi.org/10.25251/skin.7.2.5.